# TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tangent-study-design-a-phase-iii-randomized-study-of-emactuzumab-for-the-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hans Gelderblom,Emanuela Palmerini,Michiel Van De Sande,Javier Martin-Broto,Gabriel Tinoco,Elyse Seltzer,Madhu Davies,Ruth Coll,Sander Veltkamp,Jean-Yves Blay |
| Citations | 0 |
| DOI | 10.6084/m9.figshare.33033321 |
| Open Access | true |
| OA Status | green |
| OA URL | https://doi.org/10.6084/m9.figshare.33033321 |
| OpenAlex ID | https://openalex.org/W7169806472 |
| Type | dataset |
| Year | 2026 |

## Paper authors

- [Michiel Van De Sande](https://scholariq.org/researchers/michiel-van-de-sande/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.